IDEX Biometrics ASA (IDEX) Earnings Call Transcripts
IDEX Biometrics ASA's Latest Earnings Call - Q1 FY2026
In Q1 2026, IDEX Biometrics ASA reported significant developments following the launch of its Mythos authentication solution, which management described as an 'inflection point' for the company. The order backlog reached NOK 23 million, driven by new commercial orders, and the company expects strong revenue growth throughout the year as pilots are converted into full-scale deployments. Gross margins improved to 58%, while operational expenses were reduced by 44% year-on-year, indicating a focus on cost management amidst growth initiatives.
Reported metrics
| Metric | Value |
|---|---|
| Order Backlog | NOK 23 million (positive) |
| Gross Margin | 58% (positive) |
| Operational Expenses | NOK 50 million (positive) |
| Cash Position | NOK 50 million (positive) |
| Number of Pilots | 7 (positive) |
| EBITDA | lowest in a long time (neutral) |
Guidance from management
Management expects strong growth throughout 2026 as pilots convert to full-scale orders, with ongoing efforts to secure more pilots and strategic partnerships.
What analysts pressed on
Analysts expressed concerns regarding the timing of revenue recognition and the potential impact of third-party delays on pilot deployments. There is also apprehension about the sustainability of margins amidst increasing competition.
Main topics on the call
- Launch of Mythos — The launch of Mythos has fundamentally shifted enterprise authentication, with management stating, 'Mythos finds vulnerabilities faster than we can patch them.' This has led to increased engagement with customers and a g...
- Order Backlog Growth — IDEX reported an order backlog of NOK 23 million, which management attributed to the IDC order and other follow-up orders. They expect this backlog to be delivered in 2026, signaling strong demand for their products.
- Cost Management — Operational expenses were reduced by 44% year-on-year, with management indicating, 'OpEx is down 44% year-on-year, flat over the quarter.' This reflects a strong focus on cost control as the company scales its operations...
- Partnership Developments — IDEX has added 8 new channel partners, enhancing their market access. Management noted, 'The partner model is really strong,' which is expected to facilitate product deployment across Europe and Asia.
Read the full IDEX Biometrics ASA transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About IDEX Biometrics ASA
IDEX Biometrics ASA (IDEX) is a publicly listed company in the Electronic Equipment, Instruments and Components industry, within the Information Technology sector. It trades on OB and is based in NO. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 22 calls on record spanning February 27, 2020 to May 29, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 22 IDEX Biometrics ASA earnings call transcripts on record, spanning February 27, 2020 to May 29, 2026. Based on this history, IDEX Biometrics ASA reports quarterly. The most recent call on file is dated May 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- IDEX
- Exchange
- OB
- Country
- NO
- Sector
- Information Technology
- Calls on record
- 22
- First call
- February 27, 2020
- Most recent
- May 29, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q1 FY2026 | May 29, 2026 | Read transcript → |
| Q4 FY2025 | Mar 3, 2026 | Read transcript → |
| Q3 FY2024 | Oct 29, 2024 | Read transcript → |
| Shareholder/Analyst Calls | Oct 9, 2024 | Read transcript → |
| Earnings Calls | Aug 15, 2024 | Read transcript → |
| Q1 FY2024 | May 16, 2024 | Read transcript → |
| Q4 FY2023 | Feb 29, 2024 | Read transcript → |
| Q3 FY2023 | Nov 9, 2023 | Read transcript → |
| Earnings Calls | Aug 10, 2023 | Read transcript → |
| Shareholder/Analyst Calls | Jun 16, 2023 | Read transcript → |
| Shareholder/Analyst Calls | May 23, 2023 | Read transcript → |
| Q1 FY2023 | May 23, 2023 | Read transcript → |
| Q4 FY2022 | Feb 22, 2023 | Read transcript → |
| Earnings Calls | Nov 10, 2022 | Read transcript → |
| Q2 FY2022 | Aug 11, 2022 | Read transcript → |
| Q1 FY2022 | May 12, 2022 | Read transcript → |
| Q4 FY2021 | Feb 24, 2022 | Read transcript → |
| Q3 FY2021 | Nov 4, 2021 | Read transcript → |
| Special Calls | Oct 19, 2021 | Read transcript → |
| Earnings Calls | Aug 12, 2021 | Read transcript → |
| Q1 FY2020 | May 14, 2020 | Read transcript → |
| Q4 FY2019 | Feb 27, 2020 | Read transcript → |